In this newsletter …
| 1. KOL Message – Overall Survival: Some Current Events |
| 2. The Friends of Cancer Research Whitepaper Highlights: Enhancing Study Designs and Interpretation of Interim Overall Survival Data in Oncology Trials |
| 3. Estimation of OS Using RWD |
| 4. Short Course Summary: Overall Survival Analysis Methods Correcting for Treatment Switching Effects in Oncology Trials: Theory and SAS/R Code |
| 5. trtswitch Package in R |
| 6. Analysis of Cross-over Tools and Examples |
| 7. Regulatory Corner: 2025 Jan-Apr FDA Approvals in Oncology |
| 8. Biostat Bytes: Crossover, Counterfactual Model, Informative Censoring, Tipping Point |
| 9. WG Updates: KOL round table, TIRS special issue, book chapter, manuscripts, RISW and JSM accepted session and presentations |
| 10. Community news: Upcoming Conferences and PharmaDS 2025 Conference |
Download the newsletter here: https://doi.org/10.5281/zenodo.15307049.
Dahshu IDSWG Oncology 